Literature DB >> 30818043

Gut microbiota, a new frontier to understand traditional Chinese medicines.

Wuwen Feng1, Hui Ao1, Cheng Peng2, Dan Yan3.   

Abstract

As an important component of complementary and alternative medicines, traditional Chinese medicines (TCM) are gaining more and more attentions around the world because of the powerful therapeutic effects and less side effects. However, there are still some doubts about TCM because of the questionable TCM theories and unclear biological active compounds. In recent years, gut microbiota has emerged as an important frontier to understand the development and progress of diseases. Together with this trend, an increasing number of studies have indicated that drug molecules can interact with gut microbiota after oral administration. In this context, more and more studies pertaining to TCM have paid attention to gut microbiota and have yield rich information for understanding TCM. After oral administration, TCM can interact with gut microbiota: (1) TCM can modulate the composition of gut microbiota; (2) TCM can modulate the metabolism of gut microbiota; (3) gut microbiota can transform TCM compounds. During the interactions, two types of metabolites can be produced: gut microbiota metabolites (of food and host origin) and gut microbiota transformed TCM compounds. In this review, we summarized the interactions between TCM and gut microbiota, and the pharmacological effects and features of metabolites produced during interactions between TCM and gut microbiota. Then, focusing on gut microbiota and metabolites, we summarized the aspects in which gut microbiota has facilitated our understanding of TCM. At the end of this review, the outlooks for further research of TCM and gut microbiota were also discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Acetic acid(PubChem CID: 176); Aconitine (PubChem CID: 245005); Baicalin (PubChem CID: 64982); Berberine (PubChem CID: 2353); Butyric acid (PubChem CID: 264); Caffeic acid (PubChem CID: 689043); Catechin (PubChem CID: 9064); Chenodeoxycholic acid (PubChem CID: 10133); Cholic acid (PubChem CID: 221493); Daidzin (PubChem CID: 107971); Deoxycholic acid (PubChem CID: 222528); Digoxin (PubChem CID: 2724385); Dihydrodaidzein (PubChem CID: 176907); Epicatechin (PubChem CID: 72276); Geniposide (PubChem CID: 107848); Ginsenoside Rg3 (PubChem CID: 9918693); Gut microbiota; Herbal medicine; Indole (PubChem CID: 798); Linoleic acid (PubChem CID: 5280450); Lipopolysaccharide (PubChem CID: 11970143); Mercuric sulfide (PubChem CID: 62402); Metabolomics; Naringin (PubChem CID: 442428); Nodakenin (PubChem CID: 73191); Pedunculagin (PubChem CID: 442688); Phorbol (PubChem CID: 442070); Propionic acid (PubChem CID: 1032); Rhein (PubChem CID: 10168); Rutin (PubChem CID: 5280805); Secoisolariciresinol diglucoside (PubChem CID: 9917980); Sennoside a (PubChem CID: 73111); Shikonin (PubChem CID: 479503); Traditional Chinese medicine; Trimethylamine-N-oxide (PubChem CID: 1145)

Mesh:

Substances:

Year:  2019        PMID: 30818043     DOI: 10.1016/j.phrs.2019.02.024

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  77 in total

1.  Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.

Authors:  Lijuan Zhao; Hongxiang Lou; Ying Peng; Shihong Chen; Yulong Zhang; Xiaobo Li
Journal:  Endocrine       Date:  2019-10-07       Impact factor: 3.633

2.  The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.

Authors:  Zi-Yang Yi; Lin Chen; Yan Wang; Dan He; Di Zhao; Shui-Han Zhang; Rong Yu; Jian-Hua Huang
Journal:  Acta Diabetol       Date:  2022-07-20       Impact factor: 4.087

3.  Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites.

Authors:  Ling Li; Yaoyao Du; Yang Wang; Ning He; Bing Wang; Tong Zhang
Journal:  J Inflamm Res       Date:  2022-08-16

Review 4.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

5.  Therapeutic Effect of Buyang Huanwu Decoction on the Gut Microbiota and Hippocampal Metabolism in a Rat Model of Cerebral Ischemia.

Authors:  Rongmei Tang; Jian Yi; Shuangying Lu; Bowei Chen; Baiyan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 6.  Role of gut microbiota in identification of novel TCM-derived active metabolites.

Authors:  Tzu-Lung Lin; Chia-Chen Lu; Wei-Fan Lai; Ting-Shu Wu; Jang-Jih Lu; Young-Mao Chen; Chi-Meng Tzeng; Hong-Tao Liu; Hong Wei; Hsin-Chih Lai
Journal:  Protein Cell       Date:  2020-09-15       Impact factor: 14.870

Review 7.  Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery.

Authors:  Qiang Sun; Man He; Meng Zhang; Sha Zeng; Li Chen; Hui Zhao; Han Yang; Maolun Liu; Shan Ren; Haibo Xu
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

8.  Effect of You-Gui-Wan on House Dust Mite-Induced Mouse Allergic Asthma via Regulating Amino Acid Metabolic Disorder and Gut Dysbiosis.

Authors:  Wei-Hsiang Hsu; Li-Jen Lin; Chung-Kuang Lu; Shung-Te Kao; Yun-Lian Lin
Journal:  Biomolecules       Date:  2021-05-30

Review 9.  Herbal Medicine, Gut Microbiota, and COVID-19.

Authors:  Ziqi Chen; Yiwen Lv; Huachong Xu; Li Deng
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.988

10.  Therapeutic effects of Sheng Xue Fang in a cyclophosphamide-induced anaemia mouse model.

Authors:  Lu Dou; Xue Gong; Qing Wu; Fangzheng Mou
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.